IndraLab

Statements

USP1 inhibits NSCLC. 1 / 1

| 1

reach

"These findings are consistent with those of Chen et al. [XREF_BIBR], and suggest that USP1 inhibition may contribute to revert cisplatin resistance in some preclinical models of NSCLC."

23937906

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

USP1 inhibits NSCLC. 1 / 1

INDRA sources:

Databases

Reading